Naris Nilubol

7PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2026
Expanded GEP-NET organoid culture for personalized therapy evaluation.

|Jul 21, 2022
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.

Benjamin L Green, Robert R C Grant, Christopher T Richie

|Oct 20, 2021
"Cutting the Support" to Improve Treatment Efficacy in Thyroid Cancer by Targeting Tumor Microenvironment.

Naris Nilubol

|Aug 20, 2021
Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma.

Katerina Hadrava Vanova, Ying Pang, Linda Krobova

|Jul 28, 2021
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor Progression.

Johannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman

|Mar 01, 2021
First Somatic PRKAR1A Defect Associated With Mosaicism for Another PRKAR1A Mutation in a Patient With Cushing Syndrome.

Crystal D C Kamilaris, Fabio R Faucz, Victoria C Andriessen

Pageof 2

Frequent Collaborators

2 joint publications

Jaydira Del Rivero

1 joint publications

Bruna Babic

1 joint publications

Crystal D C Kamilaris

1 joint publications

Fabio R Faucz